| Value | ₹0.53 Cr |
|---|---|
| Execution period | Vesting period of minimum 1 year; Exercise period of maximum 3 years from vesting |
BSE filing, NSE: SWASTIKA. Summary written from the filing by ALFA Finder's alert engine.
Swastika Investmart Ltd: key numbers
- Share price
- ₹121.50
- Market cap
- ₹210.4 Cr
- Revenue (annual)
- ₹109.7 Cr
- Net profit (annual)
- ₹13.03 Cr
- P/E (TTM)
- 13.5×Sector 19.7×
- Promoter holding
- 59.88%+0.00% QoQ
- FII holding
- 0.52%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Swastika Investmart Ltd
All →Swastika Investmart Q2 FY27 Results: Net Profit ₹5.2 Cr, Up 57.6% YoY
Swastika Investmart Ltd reported revenue from operations of ₹29.5 Cr (+5.7% YoY) and net profit of ₹5.2 Cr (+57.6% YoY) for Q2 FY27.
- Key figure
- Net profit ₹5.2 Cr · +57.6% YoY
Swastika Investmart Employee Stock Options
Swastika Investmart granted 5,000 employee stock options to eligible employees under its ESOS 2025 scheme. Each option is convertible into one equity share.
Swastika Investmart Other Announcement
The company submitted its quarterly shareholding pattern under Regulation 31(1)(b). The notes disclose details on inter-se promoter transfers, ESOP grants, and outstanding share warrants.
Swastika Investmart Board Meeting Date
Swastika Investmart Limited scheduled a board meeting on October 21, 2026, to approve the unaudited standalone and consolidated financial results for the quarter ending September 2026.
Swastika Investmart Capital Structure Change
Swastika Investmart Limited announced that its previously allotted 90,50,000 convertible equity share warrants will now trade under the new ISIN INE691C13027.
Swastika Investmart Capital Structure Change
Swastika Investmart Limited allotted 90,50,000 convertible share warrants on a preferential basis. The company received an upfront payment of ₹14.40 Crore, representing 25% of the total consideration.
- Value
- ₹14.40 Cr
- Execution
- 18 months
Other employee stock options announcements
All →RateGain Travel Technologies Employee Stock Options
RateGain granted 53,021 Stock Appreciation Rights under its SAR Scheme 2022 at ₹800 and ₹862.25 per unit. The grants vest over four years and are exercisable within three years of vesting.
- Execution
- Vesting over 4 years (10% Y1, 20% Y2, 30% Y3, 40% Y4); exercisable within 3 years of vesting
Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.